Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Size Associations in the CRO Outsourcing Relationship

August 1, 2012

Pharmaceutical Technology

The author provides results and commentary on a survey analyzing outsourcing strategies, practices, challenges, and outcomes in the selection of a CRO.

Strategies in Outsourcing: Insourcing Emerges as an Alternative Model

August 1, 2012

Pharmaceutical Technology

AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly.

Market Strengths and Weaknesses in Biosimilars

August 1, 2012

Pharmaceutical Technology

An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.

High-Potency Manufacturing Remains Strong

July 2, 2012

Pharmaceutical Technology

Companies roll out expansions in manufacturing high-potency APIs and finished products.

35th Anniversary Special: New Models in Contract Services

July 2, 2012

Pharmaceutical Technology

Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.

Q&A with Thomas E. D'Ambra, AMRI

July 2, 2012
Pharmaceutical Technology

A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.

Reflecting on 35 Years of Procurement Transformation

July 2, 2012

Pharmaceutical Technology

The past three decades have driven a purchasing evolution to a procurement revolution.

A Look into the Future of Pharmaceutical Outsourcing: Perspectives from Jim Miller, president of PharmSource

July 2, 2012

Pharmaceutical Technology

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.

Future Innovation

July 2, 2012
Pharmaceutical Technology

Presidents of leading associations offer views on the industry's future.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here